Compounds > piperacillin
Page last updated: 2024-08-23

piperacillin and magainin 2 peptide, xenopus

piperacillin has been researched along with magainin 2 peptide, xenopus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barchiesi, F; Cirioni, O; Del Prete, MS; Drenaggi, D; Fortuna, M; Giacometti, A; Scalise, G1
Cirioni, O; Del Prete, MS; Fineo, A; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G1
Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Licci, A; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Appavu, SK1
Castelletti, S; Chiodi, L; Cirioni, O; Gabrielli, E; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C1

Other Studies

5 other study(ies) available for piperacillin and magainin 2 peptide, xenopus

ArticleYear
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:6

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Ceftazidime; Colistin; Drug Synergism; Magainins; Meropenem; Peptides; Piperacillin; Proteins; Stenotrophomonas maltophilia; Thienamycins; Xenopus Proteins

2000
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Infusions, Parenteral; Magainins; Male; Microbial Sensitivity Tests; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Treatment Outcome; Xenopus Proteins

2002
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
    Critical care medicine, 2006, Volume: 34, Issue:9

    Topics: Amphibian Proteins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacteremia; Bacterial Translocation; beta-Lactamase Inhibitors; Bile Ducts; Endotoxins; Enterococcus faecalis; Enzyme Inhibitors; Escherichia coli; Jaundice, Obstructive; Ligation; Liver; Lymph Nodes; Magainins; Male; Penicillanic Acid; Peptides; Peritoneum; Piperacillin; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Tazobactam; Tumor Necrosis Factor-alpha; Xenopus Proteins

2006
Can the ravages of uncontrolled systemic inflammatory response be regulated by amphibian antimicrobial peptides?
    Critical care medicine, 2006, Volume: 34, Issue:9

    Topics: Amphibian Proteins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Translocation; Bile Ducts; Disease Models, Animal; Endotoxins; Jaundice, Obstructive; Magainins; Penicillanic Acid; Peptides; Piperacillin; Rats; Tazobactam; Xenopus Proteins

2006
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Blood; Drug Synergism; Drug Therapy, Combination; Endotoxins; Injections, Intravenous; Magainins; Microbial Sensitivity Tests; Penicillanic Acid; Peritoneum; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Rifampin; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha; Xenopus Proteins

2008